Latest Insider Transactions at Hologic Inc (HOLX)
This section provides a real-time view of insider transactions for Hologic Inc (HOLX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HOLOGIC INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HOLOGIC INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 14
2024
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,860
-0.55%
|
$528,220
$77.54 P/Share
|
|
Nov 14
2024
|
Brandon Schnittker Div. President, GYN Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
178
-2.77%
|
$13,706
$77.54 P/Share
|
|
Nov 14
2024
|
Jan Verstreken Group President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
630
-0.6%
|
$48,510
$77.54 P/Share
|
|
Nov 14
2024
|
Karleen Marie Oberton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,332
-1.29%
|
$102,564
$77.54 P/Share
|
|
Nov 14
2024
|
Jennifer M Schneiders President, Diag. Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
507
-4.02%
|
$39,039
$77.54 P/Share
|
|
Nov 14
2024
|
John M. Griffin General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,120
-0.61%
|
$86,240
$77.54 P/Share
|
|
Nov 14
2024
|
Essex D Mitchell Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,341
-4.29%
|
$103,257
$77.54 P/Share
|
|
Nov 14
2024
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
110
-0.97%
|
$8,470
$77.54 P/Share
|
|
Nov 14
2024
|
Erik S Anderson Div. Pres., Breast & Skeletal |
SELL
Payment of exercise price or tax liability
|
Direct |
390
-1.65%
|
$30,030
$77.54 P/Share
|
|
Nov 11
2024
|
Stephen P Macmillan Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
39,677
+3.1%
|
-
|
|
Nov 11
2024
|
Brandon Schnittker Div. President, GYN Surgical |
BUY
Grant, award, or other acquisition
|
Direct |
2,834
+30.59%
|
-
|
|
Nov 11
2024
|
Jan Verstreken Group President, International |
BUY
Grant, award, or other acquisition
|
Direct |
6,298
+5.69%
|
-
|
|
Nov 11
2024
|
Karleen Marie Oberton Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,447
+8.37%
|
-
|
|
Nov 11
2024
|
Jennifer M Schneiders President, Diag. Solutions |
BUY
Grant, award, or other acquisition
|
Direct |
6,298
+33.32%
|
-
|
|
Nov 11
2024
|
Essex D Mitchell Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,021
+26.07%
|
-
|
|
Nov 11
2024
|
Benjamin Jordan Cohn Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,180
+9.41%
|
-
|
|
Nov 11
2024
|
John M. Griffin General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
6,298
+3.32%
|
-
|
|
Nov 11
2024
|
Erik S Anderson Div. Pres., Breast & Skeletal |
BUY
Grant, award, or other acquisition
|
Direct |
4,723
+16.66%
|
-
|
|
Nov 08
2024
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
68,447
-5.39%
|
$5,338,866
$78.76 P/Share
|
|
Nov 08
2024
|
Jan Verstreken Group President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
4,928
-4.78%
|
$384,384
$78.76 P/Share
|
|
Nov 08
2024
|
Karleen Marie Oberton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,598
-11.82%
|
$982,644
$78.76 P/Share
|
|
Nov 08
2024
|
Jennifer M Schneiders President, Diag. Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
125
-1.94%
|
$9,750
$78.76 P/Share
|
|
Nov 08
2024
|
Essex D Mitchell Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,383
-17.81%
|
$341,874
$78.76 P/Share
|
|
Nov 08
2024
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
190
-1.83%
|
$14,820
$78.76 P/Share
|
|
Nov 08
2024
|
John M. Griffin General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
9,299
-4.98%
|
$725,322
$78.76 P/Share
|
|
Nov 08
2024
|
Erik S Anderson Div. Pres., Breast & Skeletal |
SELL
Payment of exercise price or tax liability
|
Direct |
1,397
-6.88%
|
$108,966
$78.76 P/Share
|
|
Nov 07
2024
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,214
-0.49%
|
$490,906
$79.29 P/Share
|
|
Nov 07
2024
|
Brandon Schnittker Div. President, GYN Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
138
-3.69%
|
$10,902
$79.29 P/Share
|
|
Nov 07
2024
|
Jan Verstreken Group President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
601
-0.58%
|
$47,479
$79.29 P/Share
|
|
Nov 07
2024
|
Karleen Marie Oberton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,161
-1.08%
|
$91,719
$79.29 P/Share
|
|
Nov 07
2024
|
Jennifer M Schneiders President, Diag. Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
157
-2.38%
|
$12,403
$79.29 P/Share
|
|
Nov 07
2024
|
Essex D Mitchell Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
422
-1.69%
|
$33,338
$79.29 P/Share
|
|
Nov 07
2024
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
106
-1.01%
|
$8,374
$79.29 P/Share
|
|
Nov 07
2024
|
John M. Griffin General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
592
-0.32%
|
$46,768
$79.29 P/Share
|
|
Nov 07
2024
|
Erik S Anderson Div. Pres., Breast & Skeletal |
SELL
Payment of exercise price or tax liability
|
Direct |
344
-1.67%
|
$27,176
$79.29 P/Share
|
|
Nov 05
2024
|
Karleen Marie Oberton Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,710
+18.04%
|
-
|
|
Nov 05
2024
|
Jan Verstreken Group President, International |
BUY
Grant, award, or other acquisition
|
Direct |
17,780
+14.64%
|
-
|
|
Nov 05
2024
|
Stephen P Macmillan Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
118,560
+8.5%
|
-
|
|
Nov 05
2024
|
Essex D Mitchell Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,854
+32.13%
|
-
|
|
Nov 05
2024
|
Erik S Anderson Div. Pres., Breast & Skeletal |
BUY
Grant, award, or other acquisition
|
Direct |
4,149
+16.74%
|
-
|
|
Nov 05
2024
|
John M. Griffin General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
20,746
+9.98%
|
-
|
|
Aug 29
2024
|
Karleen Marie Oberton Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
52,679
-38.53%
|
$4,214,320
$80.56 P/Share
|
|
Aug 29
2024
|
Karleen Marie Oberton Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
32,805
+10.7%
|
$1,312,200
$40.91 P/Share
|
|
Aug 06
2024
|
Brandon Schnittker Div. President, GYN Surgical |
SELL
Open market or private sale
|
Direct |
476
-11.3%
|
$39,508
$83.11 P/Share
|
|
Aug 01
2024
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,093
-32.71%
|
$412,533
$81.99 P/Share
|
|
Jul 30
2024
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
44,039
-1.24%
|
$3,567,159
$81.45 P/Share
|
|
Jul 30
2024
|
Stephen P Macmillan Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
44,039
+3.54%
|
$1,145,014
$26.21 P/Share
|
|
Jul 17
2024
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
3,672
-0.32%
|
$293,760
$80.13 P/Share
|
|
Jul 17
2024
|
Stephen P Macmillan Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,672
+0.32%
|
$95,472
$26.21 P/Share
|
|
Jul 17
2024
|
Christiana Stamoulis Director |
SELL
Open market or private sale
|
Direct |
9,039
-16.58%
|
$714,081
$79.5 P/Share
|